fludarabine and Congenital Thrombotic Thrombocytopenic Purpura

fludarabine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baer, MR; Ding, J; Hess, JR; Zimrin, AB	1

Other Studies

1 other study(ies) available for fludarabine and Congenital Thrombotic Thrombocytopenic Purpura

Article	Year
Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura. American journal of hematology, 2018, Volume: 93, Issue:3 Topics: Adult; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Registries; Retrospective Studies; Salvage Therapy; Splenectomy; Treatment Outcome; Vidarabine; Vincristine; Young Adult	2018

Article

Year

Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura.

American journal of hematology, 2018, Volume: 93, Issue:3

Topics: Adult; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Registries; Retrospective Studies; Salvage Therapy; Splenectomy; Treatment Outcome; Vidarabine; Vincristine; Young Adult

2018